Fundamentals Hub
▼ FY 2025 Summary Analysis
Annual report ending Dec 31, 2025Overview and Growth
GeneDx Holdings Corp. generated $427.54M of revenue in fiscal 2025, with net loss of $21.02M and an operating cash inflow of $33.28M. The $427.54M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 40.0% above fiscal 2024 revenue of $305.45M, marking a year-over-year increase. The company reported diluted EPS of -$0.73, adding a shareholder-level measure to the absolute income figures considered below. Total assets stood at $523.71M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Asset turnover was 0.82x, relating the company’s annual revenue directly to the total assets reported at the period end.Profitability
Gross profit was $298.17M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. The gross-profit relationship equaled 69.7% of revenue, quantifying the portion retained before operating expenses were recognized. The company recorded an operating loss of $13.08M after the reported operating expense base. An operating margin of -3.1% reflected costs exceeding revenue-level gross profit by 3.1% of sales. The company ended the period with a net loss of $21.02M, extending the operating result through all remaining items. The net loss equaled 4.9% of revenue, showing the bottom-line deficit relative to the company’s sales base. The pretax result was a loss of $21.14M, establishing the deficit before tax effects. The pretax loss equaled 4.9% of revenue, measuring the pre-tax deficit against sales. An income-tax benefit of $116.00K improved the final result relative to pretax income or loss. The loss-to-equity relationship was 6.8%, placing the bottom-line deficit against shareholder capital. The loss-to-assets relationship was 4.0%, placing the bottom-line deficit against the company’s resource base.Liquidity and Capital Structure
The company held $523.71M of assets against $215.53M of liabilities and $308.18M of equity, revealing how the asset base was financed. The near-term balance sheet paired $268.29M of current assets with $108.91M of current liabilities at the reporting date. At 2.46x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $105.00M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 96.4% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Borrowings totaled $52.72M, adding a fixed financing obligation alongside the company’s equity capital. Debt equaled 0.17x of book equity, describing the relative scale of borrowing and shareholder capital. Relative to total assets, debt measured 10.1%, showing how much of the asset base was matched by borrowing. Relative to total assets, liabilities measured 41.2%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 20.0%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $419.38M in fiscal 2024, the current asset base moved 24.9% and finished higher. Book equity was 25.7% higher than fiscal 2024 equity of $245.25M, showing how shareholder capital changed year over year.Cash Flow and Earnings Quality
Operating activities produced a cash inflow of $33.28M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. Capital expenditures used $19.02M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital expenditures represented 57.1% of operating cash flow, leaving the remainder available as free cash flow. Free cash flow came to $14.26M, leaving a positive amount after capital expenditures. Relative to revenue, free cash flow equaled 3.3%, showing how much sales converted into cash after investment. Measured against total assets, free cash flow represented 2.7%, showing the cash productivity of the company’s assets.
Based on the annual report for the fiscal year ending Dec 31, 2025.
Analysis generated .